FIELD: pharmaceuticals.
SUBSTANCE: invention relates to regulators of steroid derivatives of formula (VIII) and their use.
EFFECT: obtaining new compounds that can be used as a regulator of the GABAA receptor for the treatment of diseases of the nervous system.
7 cl, 3 tbl, 121 ex
| Title | Year | Author | Number |
|---|---|---|---|
| REGULATORS-DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND THEIR USE | 2019 |
|
RU2797408C2 |
| COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2810331C2 |
| ORGANIC COMPOUNDS | 2019 |
|
RU2809023C2 |
| NEW CRYSTAL FORM OF VASCULAR PERMEABILITY BLOCKER COMPOUND | 2020 |
|
RU2809162C2 |
| INHIBITOR CONTAINING A TRICYCLIC DERIVATIVE, A METHOD OF ITS PRODUCTION AND ITS USE | 2019 |
|
RU2800543C2 |
| CHEMICAL COMPOUNDS AND USE THEREOF TO IMPROVE QUALITY OF MUSCLES | 2015 |
|
RU2724329C2 |
| COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | 2015 |
|
RU2733756C2 |
| MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
| SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
| INHIBITOR CONTAINING BICYCLIC DERIVATIVE, METHOD OF PREPARATION AND USE THEREOF | 2020 |
|
RU2820948C2 |
